Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xuming Wu
MDM2 Is a Useful Prognostic Biomarker for Resectable Gastric Cancer
Cancer Science
Cancer Research
Medicine
Oncology
Related publications
A Targeted Proteomics Approach Reveals a Serum Protein Signature as Diagnostic Biomarker for Resectable Gastric Cancer
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
PD-L1 Expression Combined With Microsatellite Instability/Cd8+ Tumor Infiltrating Lymphocytes as a Useful Prognostic Biomarker in Gastric Cancer
Scientific Reports
Multidisciplinary
Clinicodemographic Aspect of Resectable Pancreatic Cancer and Prognostic Factors for Resectable Cancer
World Journal of Surgical Oncology
Surgery
Oncology
Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”
Disease Markers
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics
Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker
Cancers
Cancer Research
Oncology
Angiopoietin-Like Protein 2 Is a Potential Biomarker for Gastric Cancer
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
EphA4 Is a Prognostic Factor in Gastric Cancer
BMC Clinical Pathology
Forensic Medicine
Pathology
Histology
Identification of F5 as a Prognostic Biomarker in Patients With Gastric Cancer
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Mean Platelet Volume Provides Beneficial Diagnostic and Prognostic Information for Patients With Resectable Gastric Cancer
Oncology Letters
Cancer Research
Oncology